The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Circulating MicroRNAs as biomarkers for disease staging in multiple sclerosis
Abstract
Objective: MicroRNAs (miRNAs) are single‐stranded, small noncoding RNAs that regulate gene expression. Because they are stable in serum, they are being developed as biomarkers for cancer and other diseases. In multiple sclerosis (MS), miRNAs have been studied in cell populations but not in the circulation. In MS, a major challenge is to develop immune biomarkers to monitor disease. We asked whether circulating miRNAs could be identified in MS and whether they are linked to disease stage and/or disability. Methods: A total of 368 miRNAs were measured in ethylenediaminetetraacetic acid plasma in 10 relapsing–remitting MS (RRMS) patients, 9 secondary progressive MS (SPMS) patients, and 9 healthy controls (HCs) using miRCURY LNA™ Universal RT microRNA polymerase chain reaction panels. Nineteen miRNAs from this discovery set were validated using qPCR on an independent set of 50 RRMS patients, 51 SPMS patients, and 32 HCs. Results: We found that circulating miRNAs are differentially expressed in RRMS and SPMS versus HCs and in RRMS versus SPMS. We also found miRNAs to be linked to Expanded Disability Status Scale (EDSS). hsa‐miR‐92a‐1* was identified in the largest number of comparisons. It was different in RRMS versus SPMS, and RRMS versus HCs, and showed an association with EDSS and disease duration. miR‐92 has target genes involved in cell cycle regulation and cell signaling. The let‐7 family of miRNAs differentiated SPMS from HCs and RRMS from SPMS. let‐7 miRNAs regulate stem cell differentiation and T cell activation, activate Toll‐like receptor 7, and are linked to neurodegeneration. hsa‐miR‐454 differentiated RRMS from SPMS, and hsa‐miR‐145 differentiated RRMS from HCs and RRMS from SPMS. Interestingly, the same circulating miRNAs (let‐7 and miR‐92) that were differentially expressed in RRMS versus SPMS also differentiated amyotrophic lateral sclerosis (ALS) from RRMS subjects, but were not different between SPMS and ALS, suggesting that similar processes may occur in SPMS and ALS. Interpretation: Our results establish circulating miRNAs as a readily accessible blood biomarker to monitor disease in MS. ANN NEUROL 2013;73:729–740
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Hosmer, D. W., & Lemeshow, S. (2000) · doi:10.1002/0471722146 · Cited by 20,302
Circulating microRNAs as stable blood-based markers for cancer detection
Mitchell, P. S., Parkin, R. K., Kroh, E. M., Fritz, B. R., Wyman, S. K., Pogosova-Agadjanyan, E. L., Peterson, A., Noteboom, J., O'Briant, K. C., Allen, A., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804549105 · Cited by 7,969
McDonald, W. I., Compston, A., Edan, G., Goodkin, D., Hartung, H., Lublin, F. D., McFarland, H. F., Paty, D. W., Polman, C. H., Reingold, S. C., et al. (2001) · Annals of Neurology · doi:10.1002/ana.1032 · Cited by 6,969
Non-coding RNAs in human disease
Esteller, M. (2011) · Nature Reviews Genetics · doi:10.1038/nrg3074 · Cited by 4,825
Defining the clinical course of multiple sclerosis: Results of an international survey
Lublin, F. D., Reingold, S. C., & National Multiple Sclerosis Society (USA) Advisory Committee on Clinical Trials of New Agents in Multiple Sclerosis* (1996) · Neurology · doi:10.1212/wnl.46.4.907 · Cited by 3,686
Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems
Bustin, S. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0290023 · Cited by 2,546
Roush, S., & Slack, F. J. (2008) · Trends in Cell Biology · doi:10.1016/j.tcb.2008.07.007 · Cited by 1,328
Xiao, C., Srinivasan, L., Calado, D. P., Patterson, H. C., Zhang, B., Wang, J., Henderson, J. M., Kutok, J. L., & Rajewsky, K. (2008) · Nature Immunology · doi:10.1038/ni1575 · Cited by 1,228
MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy
Kasinski, A. L., & Slack, F. J. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3166 · Cited by 936
Du, C., Liu, C., Kang, J., Zhao, G., Ye, Z., Huang, S., Li, Z., Wu, Z., & Pei, G. (2009) · Nature Immunology · doi:10.1038/ni.1798 · Cited by 811
Ponomarev, E. D., Veremeyko, T., Barteneva, N., Krichevsky, A. M., & Weiner, H. L. (2011) · Nature Medicine · doi:10.1038/nm.2266 · Cited by 787
Self-citationAn unconventional role for miRNA: let-7 activates toll-like receptor 7 and causes neurodegeneration
Lehmann, S. M., Krüger, C., Park, B., Derkow, K., Rosenberger, K., Baumgart, J., Trimbuch, T., Eom, G., Hinz, M., Kaul, D., et al. (2012) · Nature Neuroscience · doi:10.1038/nn.3113 · Cited by 786
Apetoh, L., Quintana, F. J., Pot, C., Joller, N., Xiao, S., Kumar, D., Burns, E. J., Sherr, D. H., Weiner, H. L., & Kuchroo, V. K. (2010) · Nature Immunology · doi:10.1038/ni.1912 · Cited by 725
Self-citationExtracellular microRNA: A new source of biomarkers
Etheridge, A., Lee, I., Hood, L., Galas, D., & Wang, K. (2011) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/j.mrfmmm.2011.03.004 · Cited by 659
Junker, A., Krumbholz, M., Eisele, S., Mohan, H., Augstein, F., Bittner, R., Lassmann, H., Wekerle, H., Hohlfeld, R., & Meinl, E. (2009) · Brain · doi:10.1093/brain/awp300 · Cited by 595
Modulating inflammatory monocytes with a unique microRNA gene signature ameliorates murine ALS
Butovsky, O., Siddiqui, S., Gabriely, G., Lanser, A. J., Dake, B., Murugaiyan, G., Doykan, C. E., Wu, P. M., Gali, R. R., Iyer, L. K., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62636 · Cited by 481
Self-citationKeller, A., Leidinger, P., Lange, J., Borries, A., Schroers, H., Scheffler, M., Lenhof, H.-P., Ruprecht, K., & Meese, E. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007440 · Cited by 370
Balashov, K. E., Smith, D. R., Khoury, S. J., Hafler, D. A., & Weiner, H. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.599 · Cited by 320
Self-citationLet-7 microRNA–mediated regulation of IL-13 and allergic airway inflammation
Kumar, M., Ahmad, T., Sharma, A., Mabalirajan, U., Kulshreshtha, A., Agrawal, A., & Ghosh, B. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2011.04.034 · Cited by 310
Circulating MicroRNAs as Biomarkers and Potential Paracrine Mediators of Cardiovascular Disease
Gupta, S. K., Bang, C., & Thum, T. (2010) · Circulation: Cardiovascular Genetics · doi:10.1161/circgenetics.110.958363 · Cited by 292
Silencing MicroRNA-155 Ameliorates Experimental Autoimmune Encephalomyelitis
Murugaiyan, G., Beynon, V., Mittal, A., Joller, N., & Weiner, H. L. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1003952 · Cited by 289
Self-citationDifferential Micro RNA Expression in PBMC from Multiple Sclerosis Patients
Otaegui, D., Baranzini, S. E., Armañanzas, R., Calvo, B., Muñoz-Culla, M., Khankhanian, P., Inza, I., Lozano, J. A., Castillo-Triviño, T., Asensio, A., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006309 · Cited by 245
miR‐92 is a key oncogenic component of the miR‐17–92 cluster in colon cancer
Tsuchida, A., Ohno, S., Wu, W., Borjigin, N., Fujita, K., Aoki, T., Ueda, S., Takanashi, M., & Kuroda, M. (2011) · Cancer Science · doi:10.1111/j.1349-7006.2011.02081.x · Cited by 243
Cox, M. B., Cairns, M. J., Gandhi, K. S., Carroll, A. P., Moscovis, S., Stewart, G. J., Broadley, S., Scott, R. J., Booth, D. R., Lechner-Scott, J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012132 · Cited by 239
MicroRNA-500 as a potential diagnostic marker for hepatocellular carcinoma
Yamamoto, Y., Kosaka, N., Tanaka, M., Koizumi, F., Kanai, Y., Mizutani, T., Murakami, Y., Kuroda, M., Miyajima, A., Kato, T., et al. (2009) · Biomarkers · doi:10.3109/13547500903150771 · Cited by 216
Lindberg, R. L. P., Hoffmann, F., Mehling, M., Kuhle, J., & Kappos, L. (2010) · European Journal of Immunology · doi:10.1002/eji.200940032 · Cited by 214
Altered miRNA expression in T regulatory cells in course of multiple sclerosis
De Santis, G., Ferracin, M., Biondani, A., Caniatti, L., Rosaria Tola, M., Castellazzi, M., Zagatti, B., Battistini, L., Borsellino, G., Fainardi, E., et al. (2010) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2010.06.009 · Cited by 203
Allantaz, F., Cheng, D. T., Bergauer, T., Ravindran, P., Rossier, M. F., Ebeling, M., Badi, L., Reis, B., Bitter, H., D'Asaro, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029979 · Cited by 192
Micro-RNA dysregulation in multiple sclerosis favours pro-inflammatory T-cell-mediated autoimmunity
Guerau-de-Arellano, M., Smith, K. M., Godlewski, J., Liu, Y., Winger, R., Lawler, S. E., Whitacre, C. C., Racke, M. K., & Lovett-Racke, A. E. (2011) · Brain · doi:10.1093/brain/awr262 · Cited by 188
Circulating microRNAs in cancer: origin, function and application
Ma, R., Jiang, T., & Kang, X. (2012) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-31-38 · Cited by 183
Smith, K. M., Guerau-de-Arellano, M., Costinean, S., Williams, J. L., Bottoni, A., Mavrikis Cox, G., Satoskar, A. R., Croce, C. M., Racke, M. K., Lovett-Racke, A. E., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103171 · Cited by 181
Circulating microRNAs involved in multiple sclerosis
Siegel, S. R., Mackenzie, J., Chaplin, G., Jablonski, N. G., & Griffiths, L. (2012) · Molecular Biology Reports · doi:10.1007/s11033-011-1441-7 · Cited by 179
Karni, A., Abraham, M., Monsonego, A., Cai, G., Freeman, G. J., Hafler, D., Khoury, S. J., & Weiner, H. L. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.6.4196 · Cited by 177
Self-citationFenoglio, C., Cantoni, C., De Riz, M., Ridolfi, E., Cortini, F., Serpente, M., Villa, C., Comi, C., Monaco, F., Mellesi, L., et al. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.08.021 · Cited by 176
Qi, J., Qiao, Y., Wang, P., Li, S., Zhao, W., & Gao, C. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.03.011 · Cited by 170
Lowery, A., Miller, N., McNeill, R. E., & Kerin, M. J. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0992 · Cited by 156
Differential Regulation of the Let-7 Family of MicroRNAs in CD4+ T Cells Alters IL-10 Expression
Swaminathan, S., Suzuki, K., Seddiki, N., Kaplan, W. H., Cowley, M. J., Hood, C. L., Clancy, J. L., Murray, D. D., Méndez, C., Gelgor, L., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1101196 · Cited by 144
Viader, A., Chang, L., Fahrner, T. J., Nagarajan, R., & Milbrandt, J. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.3931-11.2011 · Cited by 130
The emerging role of microRNAs in multiple sclerosis
Junker, A., Hohlfeld, R., & Meinl, E. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.179 · Cited by 129
Altered microRNA expression in B lymphocytes in multiple sclerosis
Sievers, C., Meira, M., Hoffmann, F., da Fontoura, P. P., Kappos, L., & Lindberg, R. L. P. (2012) · Clinical Immunology · doi:10.1016/j.clim.2012.04.002 · Cited by 121
MicroRNAs in multiple sclerosis and experimental autoimmune encephalomyelitis.
Thamilarasan, M., Koczan, D., Hecker, M., Paap, B., & Zettl, U. (2012) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.05.009 · Cited by 119
Fayyad‐Kazan, H., Rouas, R., Fayyad‐Kazan, M., Badran, R., Zein, N. E., Lewalle, P., Najar, M., Hamade, E., Jebbawi, F., Merimi, M., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.337154 · Cited by 107
miR-140-3p regulation of TNF-α-induced CD38 expression in human airway smooth muscle cells.
Jude, J., Dileepan, M., Subramanian, S., Solway, J., Panettieri, R., Walseth, T., & Kannan, M. (2012) · American Journal of Physiology - Lung cellular and Molecular Physiology · doi:10.1152/ajplung.00041.2012 · Cited by 104
Grigoryev, Y. A., Kurian, S. M., Hart, T., Nakorchevsky, A., Chen, C., Campbell, D., Head, S. R., Yates, J. R., & Salomon, D. R. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.1101233 · Cited by 103
MiR-135a targetsJAK2and inhibits gastric cancer cell proliferation
Wu, H., Huang, M., Cao, P., Wang, T., Shu, Y., & Liu, P. (2012) · Cancer Biology & Therapy · doi:10.4161/cbt.18943 · Cited by 98
Boneschi, F. M., Fenoglio, C., Brambilla, P., Sorosina, M., Giacalone, G., Esposito, F., Serpente, M., Cantoni, C., Ridolfi, E., Rodegher, M., et al. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.11.006 · Cited by 97
Karni, A. (2002) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(02)00018-8 · Cited by 95
MicroRNAs and Multiple Sclerosis
Tüfekçi, K. U., Öner, M. G., Genç, Ş., & Genç, K. (2010) · Autoimmune Diseases · doi:10.4061/2011/807426 · Cited by 86
miRNA profiling for biomarker discovery in multiple sclerosis: From microarray to deep sequencing
Guerau‐de‐Arellano, M., Alder, H., Özer, H. G., Lovett‐Racke, A. E., & Racke, M. K. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.10.006 · Cited by 86
High expression of miR-210 predicts poor survival in patients with breast cancer: A meta-analysis
Liu, H., Yang, J., Han, Y., Lu, Q., Cao, J., & Syed, L. H. (2012) · Gene · doi:10.1016/j.gene.2012.07.025 · Cited by 85
Integration of MicroRNA Databases to Study MicroRNAs Associated with Multiple Sclerosis
Angerstein, C., Hecker, M., Paap, B. K., Koczan, D., Thamilarasan, M., Thiesen, H., & Zettl, U. K. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8270-0 · Cited by 58
Pathophysiology of translational regulation by microRNAs in multiple sclerosis
Junker, A. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.052 · Cited by 58
Differentially expressed microRNAs regulate plasmacytoid vs. conventional dendritic cell development
Kuipers, H., Schnorfeil, F. M., & Brocker, T. (2010) · Molecular Immunology · doi:10.1016/j.molimm.2010.07.007 · Cited by 52
Disease protection and interleukin‐10 induction by endogenous interferon‐β in multiple sclerosis?
Hesse, D., Krakauer, M., Lund, H., Søndergaard, H. B., Limborg, S., Sørensen, P. S., & Sellebjerg, F. T. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03116.x · Cited by 46
Qiu, X.-F., Li, X.-X., Chen, Y., Lin, H.-C., Yu, W., Wang, R., & Dai, Y.-T. (2012) · Asian Journal of Andrology · doi:10.1038/aja.2011.161 · Cited by 39
Membrane bound IL-15 is increased on CD14 monocytes in early stages of MS
Vaknin‐Dembinsky, A., Brass, S. D., Gandhi, R., & Weiner, H. L. (2008) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2008.01.016 · Cited by 28
Self-citationEisele, S. C., Krumbholz, M., Fischer, M., Mohan, H., Junker, A., Arzberger, T., Hohlfeld, R., Bradl, M., Lassmann, H., & Meinl, E. (2012) · Brain Pathology · doi:10.1111/j.1750-3639.2012.00564.x · Cited by 26
Cited by
Multiple Sclerosis: Mechanisms and Immunotherapy
Baecher-Allan, C., Kaskow, B. J., & Weiner, H. L. (2018) · Neuron · doi:10.1016/j.neuron.2018.01.021 · Cited by 938
Self-citationMyasthenia gravis: A comprehensive review of immune dysregulation and etiological mechanisms
Berrih-Aknin, S., & Le Panse, R. (2014) · Journal of Autoimmunity · doi:10.1016/j.jaut.2013.12.011 · Cited by 383
The role of miRNA in inflammation and autoimmunity
Singh, R. P., Massachi, I., Manickavel, S., Singh, S., Rao, N. P., Hasan, S., Mc Curdy, D. K., Sharma, S., Wong, D., Hahn, B. H., et al. (2013) · Autoimmunity Reviews · doi:10.1016/j.autrev.2013.07.003 · Cited by 334
Circulating microRNAs in breast cancer: novel diagnostic and prognostic biomarkers
Hamam, R., Hamam, D., Alsaleh, K. A., Kassem, M., Zaher, W., Alfayez, M., Aldahmash, A., & Alajez, N. M. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.440 · Cited by 322
Baumann, V., & Winkler, J. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.116 · Cited by 297
Metadata
- Authors
- Gandhi, R., Healy, B., Gholipour, T., Egorova, S., Musallam, A., Hussain, M. S., Nejad, P., Patel, B., Hei, H., Khoury, S., Quintana, F., Kivisakk, P., Chitnis, T., & Weiner, H. L.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2013-06
- Volume
- 73
- Issue
- 6
- Pages
- 729-740
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W1588752417
- Cited by
- 258
- References
- 58
- FWCI
- 20.24
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.